Skip to main content
. 2021 Jun 15;3(2):221–232. doi: 10.1016/j.jaccao.2021.03.006

Table 3.

Landmark Analysis: Risk of Atrial Fibrillation at 90 Days, 1 Year, and 5 Years After a Cancer Diagnosis

Noncancer Control Subjects Cancer Patients
90 days
 Number 1,631,826 813,650
 Events 30,326 23,005
 Duration, person-years 8,392,491 3,612,754
 Time to event, yrs 3.11 (1.58–4.92) 1.61 (0.88–3.21)
 Incidence 3.61 6.37
 Model 1: Subdistribution HR (95% CI) Reference 1.57 (1.54–1.59)
 Model 2: Subdistribution HR (95% CI) Reference 1.56 (1.54–1.59)
1 yr
 Number 1,623,932 790,183
 Events 26,800 18,180
 Duration, person-years 7,165,685 3,006,675
 Time to event, yrs 2.74 (1.32–4.40) 1.25 (0.60–3.08)
 Incidence 3.74 6.05
 Model 1: Subdistribution HR (95% CI) Reference 1.45 (1.42–1.48)
 Model 2: Subdistribution HR (95% CI) Reference 1.44 (1.42–1.47)
5 yrs
 Number 952,163 374,557
 Events 8,187 2,982
 Duration, person-years 1,802,692 683,875
 Time to event, yrs 1.21 (0.56–2.05) 1.16 (0.53–1.98)
 Incidence 4.54 4.36
 Model 1: Subdistribution HR (95% CI) Reference 1.09 (1.04–1.14)
 Model 2: Subdistribution HR (95% CI) Reference 1.08 (1.03–1.12)

Values are median (interquartile range), unless otherwise indicated. Death was considered a competing risk in Fine and Gray’s competing risk regression model. Model 1: adjusted for age and sex; model 2: adjusted for age, sex, smoking, drinking, regular exercise, socioeconomic status, diabetes mellitus, hypertension, dyslipidemia, body mass index, and chronic kidney disease.

Abbreviations as in Table 2.

Per 1,000 person-years.